Myocardial protection by protykin, a novel extract of trans-resveratrol and emodin

Free Radical Research

Volumn 32, Issue 2, 2000, Pages 135-144

  Sato, Motoaki ^a   Maulik, Gautam ^b   Bagchi, Debasis ^c   Das, Dipak K ^a  

^a UNIVERSITY OF CONNECTICUT SCHOOL OF MEDICINE   (United States)

^b HARVARD MEDICAL SCHOOL   (United States)

^c CREIGHTON UNIVERSITY SCHOOL OF PHARMACY AND HEALTH PROFESSIONS   (United States)

Author keywords

Antioxidant; Cardioprotection; Emodin; Flavonoids; Grape; Heart; Hydroxyl radical; Ischemia reperfusion; Peroxyl radical; Protykin; Red wine; Resveratrol

Indexed keywords

2,2' AZOBIS(2 AMIDINOPROPANE); CORN OIL; EMODIN; FREE RADICAL; HYDROXYL RADICAL; MALONALDEHYDE; PEROXY RADICAL; PLANT EXTRACT; PROTYKIN; RESVERATROL; SCAVENGER; UMBELLIFERONE DERIVATIVE; UNCLASSIFIED DRUG;

ANGIOSPERM; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIINFLAMMATORY ACTIVITY; ARTICLE; CHINESE HERB; CONTROLLED STUDY; DRUG POTENCY; HEART INFARCTION SIZE; HEART LEFT VENTRICLE DP-DT; HEART LEFT VENTRICLE FUNCTION; HEART MUSCLE ISCHEMIA; HEART PROTECTION; MALE; NONHUMAN; OXIDATIVE STRESS; PLANT ROOT; RAT; REPERFUSION INJURY; TRANS ISOMER;

POLYGONUM CUSPIDATUM;

EID: 0033979253     PISSN: 10715762     EISSN: None     Source Type: Journal    
DOI: 10.1080/10715760000300141     Document Type: Article

References (43)

1. S. Renaud and M. De Lorgeril (1993) Wine, alcohol, platelets and the French Paradox for coronary heart disease. Lancet 342: 1007-1011.
2. M.G.L. Hertog, E.J.M. Feskens and D. Kromhout (1997) Antioxidant flavonols and coronary heartdisease risk. Lancet 349: 699.
3. J.J.F. Belch, A.B. Bridges, N. Scott and M. Chopra (1991) Oxygen free radicals and congestive heart failure. British Heart Journal 65: 245-248.
4. P.K. Singal, N. Kapur, K.S. Dhillon, R.E. Beamish and N.S. Dhalla (1982) Role of free radicals in catecholamine-inducedcardiomopathy. Canadian Journal of Physiology and Pharmacology 60: 1390-1397.
5. H. Otani, R.M. Engelman, J.A. Rousou, R.H. Breyer and D.K. Das (1986a) Enhanced prostaglandin synthesis due to phospholipase breakdown in ischemic-reperfused myocardium. Control of its production by a phospholipase inhibitor or free radical scavengers. Journal of Molecular and Cellular Cardiology 18: 953-961.
6. H. Otani, R.M. Engelman, J.A. Rousou, R.H. Breyer, S. Lemeshow and D.K. Das (1986b) Cardiac performance during reperfusion improved by pretreatment with oxygen free radical scavengers. Journal of Thoracic and Cardiovascular Surgery 91: 290-295.
7. U.P. Steinbrecher, H. Zhang and M. Lougheed Role of oxidatively modified LDL in atherosclerosis (1990) Free Radical Biology and Medicine 9: 155-168.
8. D.K. Das and N. Maulik (1995) Protection against free radical injury in the heart and cardiac performance. In: Exercise and Oxygen Toxicity (C.K. Sen, L. Packer and O. Hanninen, Eds.), Elsevier Science, Amsterdam.
9. K.F. Gay, P. Puska, P. Jordan and U.K. Moser (1991) Inverse correlation between plasma vitamin E and mortality from ischemic heart disease in cross-cultural epidemiology. American Journal of Clinical Nutrition 53: 3265-3345.
10. K.F. Gay (1986) On the antioxidant hypothesis with regard to arteriosclerosis, Bibl Nutrition Dieta 37: 53-91.
11. D. Engelman, M. Watanabe, R.M. Engelman, J.A. Rousou, E. Kisin, V.E. Kagan, N. Maulik and D.K. Das (1995) Hypoxic preconditioning preserves antioxidant reserve in the working rat heart. Cardiovascular Research 29: 133-140.
12. T. Yoshida, M. Watanabe, D.T. Engelman, R.M. Engelman, J.A. Schley, N. Maulik, Y.-S. Ho, T.D. Oberley and D.K. Das (1996) Transgenic mice overexpressing glutathione peroxidase are resistant to myocardial ischemia reperfusion injury. Journal of Molecular and Cellular Cardiology 28: 1759-1767.
13. G.A. Cordis, N. Maulik and D.K. Das (1995) Detection of oxidative stress in heart by estimating the dinitrophenyl-hydrazine derivative of malonaldehyde. Journal of Molecular and Cellular Cardiology 27: 1645-1653.
14. G.M. Makrigiorgos, A. Kassis, A. Mahmood, E. Bump and P. Savvides (1997) Novel fluorescein-based flow cytometric method for detection of lipid peroxidation. Free Radical Biology and Medicine 22: 93-100.
15. A.K. Collins, G.M. Makrigiorgos and G.K. Svensson (1994) Coumarin chemical dosimeter for radiation therapy. Medical Physics 21: 1741-1747.
16. G.A. Cordis, G. Maulik, D. Bagchi, W. Riedel and D.K. Das (1998) Detection of oxidative DNA damage to ischemic reperfused rat hearts by 8-hydroxydeoxyguanosine formation. Journal of Molecular and Cellular Cardiology 30: 1934-1944.
17. D.K. Das and N. Maulik (1994) Evaluation of antioxidant effectiveness in ischemia reperfusion tissue injury methods. Methods in Enzymology 233: 601-610.
18. C.M. Arroyo, J.H. Kramer, B.F. Dickens and W.B. Weglicki (1987) Identification of free radicals in myocardial ischemia/reperfusion by spin trapping with nitrone DMPO. FEBS Letter 221: 101-104.
19. N. Maulik, M. Watanabe, D. Engelman, R.M. Engelman, V.E. Kagan, E. Kisin, V. Tyurin, G.A. Cordis and D.K. Das (1995) Myocardial adaptation to ischemia by oxidative stress induced by endotoxin. American Journal of Physiology 269:C907-C916.
20. A. Tosaki, D. Bagchi, T. Hellegouarch, T. Pali, G.A. Cordis and D.K. Das (1993) Comparisons of ESR and HPLC methods for the detection of hydroxyl radicals in ischemic/reperfused hearts. A relationship between the genesis of oxygen-free radicals and reperfusion-induced arrhythmias. Biochemical Pharmacology 45: 961-969.
21. R. Roots and S. Okada (1975) Estimation of life times and diffusion distances of radicals involved in X-ray induced DNA strand breaks or killing of mammalian cells. Radiation Research 64: 306-320.
22. B. Chance, H. Sies and A. Boveris (1979) Hydroperoxide metabolism in mammalian organs. Physiological Review 59: 527-540.
23. B. Frei, R. Stocker and B.N. Ames (1988) Antioxidant defenses and lipid peroxidation in human blood plasma. Proceedings of National Academy of Sciences (USA) 85: 9748-9751.
24. R. Stocker and E. Peterhans (1989) Synergistic interaction between vitamin E and the bile pigments bilirubin and biliverdin. Biochimica Biophysica Acta 1002: 238-243.
25. D.J. Hearse and A.J. Roberts Eds. (1987) New York: Marcel Dekker, pp. 7-17.
26. D.K. Das, R.M. Engelman, J.A. Rousou, R.H. Breyer, H. Otani and S. Lemeshow (1986) Pathophysiology of superoxide radical as potential mediator of ischemic and reperfusion injury in pig heart. Basic Research in Cardiology 81: 155-166.
27. L. Zhang, S.S. Bacus, C.J. Chang and M.C. Hung (1995) Suppressed transformation and induced differentiation of HER-2/neu-overexpressing breast cancer cells by emodin. Cancer Research 55: 3890-3896.
28. F. Uenobe, M. Miyazawa and S. Nakamura (1997) Antimutagenic effect of resveratrol against Trp-1. Mutation Research 373: 197-199.
29. G.J. Soleas, E.P. Diamandis and D.M. Goldberg (1997) Wine as a biological fluid: history, production and role in disease prevention. Journal of Clinical Laboratory Analysis 11: 287-313.
30. M. Jang, L. Cai and G.O. Udeani (1997) Cancer chemopreventive activity of resveratrol, a natural product derived from grapes. Science 275: 218-220.
31. A.Y. Sun, Y.M. Chen and M. James-Kracke (1997) Ethanol-induced cell death by lipid peroxidation in PC12 cells. Neurochemical Research 22: 1187-1192.
32. C.K. Chen and C.R. Pace-Asciak (1996) Vasorelaxing activity of resveratrol and quercetin in isolated rat aorta. General Pharmacology 27: 363-366.
33. H.S. Huang, S.H. Chu and P.D. Lee (1991) Vasorelaxants from Chinese herbs, emodin and scoparone, possess immunosuppressive properties. Eurorean Journal of Pharmacology 198: 211-216.
34. D.F. Liberman, R.C. Fink, F.L. Shaofers, R.J. Mulchay and A.A. Stark (1993) Mutagenicity of anthroquinone and hydroxylated anthroquinones in the Ames/Salmonella microsome syste. Applied Environmental Microbiology 43: 1354-1359.
35. Y.-C. Kuo, C.-M. Sun, J.-C. Ou and W.-J. Tsai (1997) A tumor cell growth inhibitor from Polygonum hypolecum ohwai. Life Sciences 61: 2335-2344.
36. C.M. Teng, C.H. Lin, C.N. Lin, M.I. Chung and T.F. Huang (1993) Frangulin B, an antagonist of collagen-induced platelet aggregation and adhesion, isolated from Rhamus formosana. Thrombosis Haemostasis 70: 1014-1018.
37. J.M. Gaziano, J.E. Buring, J.L. Breslow, S.Z. Goldhaber, B. Rosner, M. VanDenburgh, W. Willett and C.H. Henekens (1993) Moderate alcohol intake, increased levels of high-density lipoprotein and its sub-fractions and decreased risk of myocardial infarction. New England Journal of Medicine 329: 1829-1834.
38. E.N. Frankel, J. Kanner and J.B. German (1993) Inhibition of human low-density lipoprotein by phenolic substances in red wine. Lancet 341: 454-457.
39. P.M. Ridker, D.E. Vaughan, M.J. Stampfer, R.J. Glynn and C.H. Hennekens (1994) Association of moderate alcohol consumption and plasma concentration of tissue-type plasminogen activator. Journal of American Medical Association 272: 929-933.
40. D.P. Mikhailidis, J.Y. Jeremy, M.A. Barradas, N. Green and P. Dandona (1993) Effect of ethanol on vascular prostacyclin synthesis, platelet aggregation and platelet thromboxane release. British Medical Journal 87: 1495-1498.
41. H. Demrow, P. Slane and J. Folts (1995) Administration of wine and grape juice inhibits in vivo platelet activity and thrombosis in stenosed canine coronary arteries. Circulation 91: 1182-1188.
42. A. Saija, D. Marzullo, M. Scalese, F. Bonina, M. Laiza and F. Castelli (1995) Flavonoids as antioxidant agents: importance of their interaction with biomembranes. Free Radical Biology and Medicine 19: 481-486.
43. C. Rice-Evans, N.J. Miller and G. Paganga (1996) Structure-antioxidant activity relationships of flavonoids and phenolic acids. Free Radical Biology and Medicine 20: 933-956.